Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease von DuPage, Michel, Bluestone, Jeffrey A.

Volltext

Treg cell-based therapies: challenges and perspectives von Raffin, Caroline, Vo, Linda T., Bluestone, Jeffrey A.

Volltext

T-reg cell-based therapies: challenges and perspectives von Raffin, Caroline, Vo, Linda T., Bluestone, Jeffrey A.

Volltext

CD28 Costimulation: From Mechanism to Therapy von Esensten, Jonathan H., Helou, Ynes A., Chopra, Gaurav, Weiss, Arthur, Bluestone, Jeffrey A.

Volltext

Is autoimmunity the Achilles' heel of cancer immunotherapy? von June, Carl H, Warshauer, Jeremy T, Bluestone, Jeffrey A

Volltext

Tolerance in the Age of Immunotherapy von Bluestone, Jeffrey A, Anderson, Mark

Volltext

Immunotherapy: Building a bridge to a cure for type 1 diabetes von Bluestone, Jeffrey A., Buckner, Jane H., Herold, Kevan C.

Volltext

Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines von Kang, Jee Hye, Bluestone, Jeffrey A., Young, Arabella

Volltext

Genetics, pathogenesis and clinical interventions in type 1 diabetes von Herold, Kevan, Bluestone, Jeffrey A, Eisenbarth, George

Volltext

Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response von Bailey-Bucktrout, Samantha L., Martinez-Llordella, Marc, Zhou, Xuyu, Anthony, Bryan, Rosenthal, Wendy, Luche, Herve, Fehling, Hans J., Bluestone, Jeffrey A.

Volltext

The Foxp3 + regulatory T cell: a jack of all trades, master of regulation von Bluestone, Jeffrey A, Tang, Qizhi

Volltext

New Frontiers in the Treatment of Type 1 Diabetes von Warshauer, Jeremy T., Bluestone, Jeffrey A., Anderson, Mark S.

Volltext

Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges von Sneddon, Julie B., Tang, Qizhi, Stock, Peter, Bluestone, Jeffrey A., Roy, Shuvo, Desai, Tejal, Hebrok, Matthias

Volltext

The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy von Young, Arabella, Quandt, Zoe, Bluestone, Jeffrey A

Volltext

The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation von DuPage, Michel, Chopra, Gaurav, Quiros, Jason, Rosenthal, Wendy L, Morar, Malika M, Holohan, Dan, Zhang, Ruan, Turka, Laurence, Marson, Alexander, Bluestone, Jeffrey A

Volltext

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation von Molofsky, Ari B., Van Gool, Frédéric, Liang, Hong-Erh, Van Dyken, Steven J., Nussbaum, Jesse C., Lee, Jinwoo, Bluestone, Jeffrey A., Locksley, Richard M.

Volltext

Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier von Esensten, Jonathan H., Muller, Yannick D., Bluestone, Jeffrey A., Tang, Qizhi

Volltext

Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis von Komatsu, Noriko, Okamoto, Kazuo, Sawa, Shinichiro, Nakashima, Tomoki, Oh-hora, Masatsugu, Kodama, Tatsuhiko, Tanaka, Sakae, Bluestone, Jeffrey A, Takayanagi, Hiroshi

Volltext

Next-generation regulatory T cell therapy von Ferreira, Leonardo M. R., Muller, Yannick D., Bluestone, Jeffrey A., Tang, Qizhi

Volltext

Peripherally induced tregs - role in immune homeostasis and autoimmunity von Yadav, Mahesh, Stephan, Stephen, Bluestone, Jeffrey A

Volltext